Disturbances in Heart Rhythm
Mechanism of Cardiac Arrhythmias
Inflammatory Bowel Disease I: Ulcerative Colitis
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 14, 2025

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Carlos H Pereira1, Hiroki Kittaka1, Edward J Ouille V1
1Department of Internal Medicine/Cardiology, Rush University Medical Center, 1750 W. Harrison St., Chicago, IL 60612, USA.
Inflammatory bowel disease increases arrhythmia risk by altering heart calcium handling via the renin-angiotensin system. Inhibiting this system (ACE or AT1R blockers) may prevent these cardiac changes.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: